Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R.

N Engl J Med. 2002 Feb 14;346(7):491-6.

2.

Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.

Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D.

Hum Vaccin Immunother. 2015;11(3):632-41. doi: 10.4161/hv.34414.

3.

Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.

Fattom A, Fuller S, Propst M, Winston S, Muenz L, He D, Naso R, Horwith G.

Vaccine. 2004 Dec 16;23(5):656-63.

PMID:
15542186
4.

Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis.

Welch PG, Fattom A, Moore J Jr, Schneerson R, Shiloach J, Bryla DA, Li X, Robbins JB.

J Am Soc Nephrol. 1996 Feb;7(2):247-53.

5.

Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.

Robbins JB, Schneerson R, Horwith G, Naso R, Fattom A.

Am Heart J. 2004 Apr;147(4):593-8.

PMID:
15077073
6.

Staphylococcus aureus vaccine conjugate--Nabi: Nabi-StaphVAX, StaphVAX.

[No authors listed]

Drugs R D. 2003;4(6):383-5. Review.

PMID:
14584973
7.

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, Kossaczka Z, Bryla DA, Shiloach J, Robbins JB, Schneerson R, Szu SC.

N Engl J Med. 2001 Apr 26;344(17):1263-9.

8.
9.

Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.

Creech CB 2nd, Johnson BG, Alsentzer AR, Hohenboken M, Edwards KM, Talbot TR 3rd.

Vaccine. 2009 Dec 10;28(1):256-60. doi: 10.1016/j.vaccine.2009.09.088.

PMID:
19799842
10.

Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia.

Roghmann M, Taylor KL, Gupte A, Zhan M, Johnson JA, Cross A, Edelman R, Fattom AI.

J Hosp Infect. 2005 Jan;59(1):27-32.

PMID:
15571850
11.

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Santosham M, Wolff M, Reid R, Hohenboken M, Bateman M, Goepp J, Cortese M, Sack D, Hill J, Newcomer W, et al.

N Engl J Med. 1991 Jun 20;324(25):1767-72.

12.

Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.

Moustafa M, Aronoff GR, Chandran C, Hartzel JS, Smugar SS, Galphin CM, Mailloux LU, Brown E, Dinubile MJ, Kartsonis NA, Guris D.

Clin Vaccine Immunol. 2012 Sep;19(9):1509-16. doi: 10.1128/CVI.00034-12.

13.

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

Fowler VG, Allen KB, Moreira ED, Moustafa M, Isgro F, Boucher HW, Corey GR, Carmeli Y, Betts R, Hartzel JS, Chan IS, McNeely TB, Kartsonis NA, Guris D, Onorato MT, Smugar SS, DiNubile MJ, Sobanjo-ter Meulen A.

JAMA. 2013 Apr 3;309(13):1368-78. doi: 10.1001/jama.2013.3010.

PMID:
23549582
14.

Preclinical laboratory evaluation of a bivalent Staphylococcus aureus saccharide-exotoxin A protein conjugate vaccine.

Ho MM, Bolgiano B, Martino A, Kairo SK, Corbel MJ.

Hum Vaccin. 2006 May-Jun;2(3):89-98.

PMID:
17012902
15.

Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site.

Lentino JR, Baddour LM, Wray M, Wong ES, Yu VL.

Infection. 2000 Nov-Dec;28(6):355-60.

PMID:
11139154
16.

Vaccine could help fight deadly hospital-acquired infections.

Levenson D.

Rep Med Guidel Outcomes Res. 2002 Mar 22;13(6):9-10, 12. No abstract available.

PMID:
12449105
17.

Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.

Fattom AI, Horwith G, Fuller S, Propst M, Naso R.

Vaccine. 2004 Feb 17;22(7):880-7. Review.

PMID:
15040941
18.

Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment.

Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, Draibe S, Pignatari AC.

J Am Soc Nephrol. 1998 Jun;9(6):1085-92.

19.

Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.

Fattom A, Schneerson R, Watson DC, Karakawa WW, Fitzgerald D, Pastan I, Li X, Shiloach J, Bryla DA, Robbins JB.

Infect Immun. 1993 Mar;61(3):1023-32.

20.
Items per page

Supplemental Content

Support Center